Peking University First Hospital
Clinical trials sponsored by Peking University First Hospital, explained in plain language.
-
New drug shows promise for painful hand and foot pustules
Disease control TerminatedThis study tested the drug deucravacitinib in people with moderate-to-severe palmoplantar pustulosis, a skin condition that causes painful pus-filled blisters on the palms and soles. The goal was to see if the drug could reduce the severity of the pustules and improve quality of …
Phase: NA • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
Painkiller study halted early – only 13 patients enrolled
Symptom relief TerminatedThis study tested a drug called anrikefon to see if it could better control pain after laparoscopic surgery. The trial was stopped early and only included 13 people, so the results are not reliable. The goal was to improve pain relief, but the study's small size and early termina…
Phase: PHASE4 • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated May 17, 2026 05:35 UTC